PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
(NASDAQ: PYPD) Delayed: 5.03 -0.18 (3.45%)
Previous Close $5.21    52 Week High $ 
Open $5.25    52 Week Low $ 
Day High $5.34    P/E N/A 
Day Low $5.03    EPS $ 
Volume 104,967